232 related articles for article (PubMed ID: 18035056)
21. Effect of glucagon on renal excretion of oxypurinol and purine bases.
Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hiroishi K; Yamakita J; Nakano T; Higashino K
J Rheumatol; 1997 Apr; 24(4):708-13. PubMed ID: 9101506
[TBL] [Abstract][Full Text] [Related]
22. Effect of octreotide acetate on the plasma concentration and urinary excretion of uridine and purine bases.
Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Ka T; Hada T
Endocr J; 2002 Apr; 49(2):139-44. PubMed ID: 12081231
[TBL] [Abstract][Full Text] [Related]
23. Effect of amino acids on the plasma concentration and urinary excretion of uric acid and uridine.
Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Ohata H; Yamakita J; Nakamo T; Higashino K
Metabolism; 1999 Aug; 48(8):1023-7. PubMed ID: 10459568
[TBL] [Abstract][Full Text] [Related]
24. Bioavailability of anthocyanidin-3-glucosides following consumption of red wine and red grape juice.
Frank T; Netzel M; Strass G; Bitsch R; Bitsch I
Can J Physiol Pharmacol; 2003 May; 81(5):423-35. PubMed ID: 12774848
[TBL] [Abstract][Full Text] [Related]
25. Effect of losartan potassium, an angiotensin II receptor antagonist, on renal excretion of oxypurinol and purine bases.
Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hada T
J Rheumatol; 2000 Sep; 27(9):2232-6. PubMed ID: 10990239
[TBL] [Abstract][Full Text] [Related]
26. Effects of fructose and xylitol on the urinary excretion of adenosine, uridine, and purine bases.
Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Yamakita J; Higashino K
Metabolism; 1999 Apr; 48(4):520-4. PubMed ID: 10206448
[TBL] [Abstract][Full Text] [Related]
27. Effect of glucagon on the xylitol-induced increase in the plasma concentration and urinary excretion of purine bases.
Yamamoto T; Moriwaki Y; Takahashi S; Ohata H; Nakano T; Yamakita J; Higashino K
Metabolism; 1996 Nov; 45(11):1354-9. PubMed ID: 8931639
[TBL] [Abstract][Full Text] [Related]
28. Effect of bucladesine sodium on the plasma concentrations and urinary excretion of purine bases and uridine.
Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Ohata H; Fujita T; Yamakita J; Nakano T; Hiroishi K; Higashino K
Metabolism; 1998 Aug; 47(8):1005-8. PubMed ID: 9712000
[TBL] [Abstract][Full Text] [Related]
29. Purine metabolism in women with primary gout.
Puig JG; Mateos FA; Miranda ME; Torres RJ; de Miguel E; Pérez de Ayala C; Gil AA
Am J Med; 1994 Oct; 97(4):332-8. PubMed ID: 7942934
[TBL] [Abstract][Full Text] [Related]
30. Effects of a fenofibrate/losartan combination on the plasma concentration and urinary excretion of purine bases.
Ka T; Inokuchi T; Tsutsumi Z; Takahashi S; Moriwaki Y; Yamamoto T
Int J Clin Pharmacol Ther; 2006 Jan; 44(1):22-6. PubMed ID: 16425967
[TBL] [Abstract][Full Text] [Related]
31. Responses of blood and plasma lactate and plasma purine concentrations to maximal exercise and their relation to performance in standardbred trotters.
Räsänen LA; Lampinen KJ; Pösö AR
Am J Vet Res; 1995 Dec; 56(12):1651-6. PubMed ID: 8599528
[TBL] [Abstract][Full Text] [Related]
32. Effect of furosemide on renal excretion of oxypurinol and purine bases.
Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hada T
Metabolism; 2001 Feb; 50(2):241-5. PubMed ID: 11229436
[TBL] [Abstract][Full Text] [Related]
33. Effect of glucagon on the plasma concentration of uridine.
Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Ohata H; Yamakita J; Nakano T; Hiroishi K; Higashino K
Metabolism; 1998 Jun; 47(6):695-8. PubMed ID: 9627369
[TBL] [Abstract][Full Text] [Related]
34. [Mechanism of exercise-induced hyperuricemia].
Hadano S; Ogasawara M; Ito A
Nihon Seirigaku Zasshi; 1987; 49(5):151-9. PubMed ID: 3681743
[TBL] [Abstract][Full Text] [Related]
35. Effect of norepinephrine on the urinary excretion of purine bases and oxypurinol.
Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hada T
Metabolism; 2001 Oct; 50(10):1230-3. PubMed ID: 11586499
[TBL] [Abstract][Full Text] [Related]
36. Effect of DL-sodium lactate infusion on excretion of purine bases and oxypurinol.
Yamamoto T; Moriwaki Y; Takahashi S; Nasako Y; Higashino K
Int J Clin Pharmacol Ther Toxicol; 1993 Dec; 31(12):588-92. PubMed ID: 8314359
[TBL] [Abstract][Full Text] [Related]
37. The effect of completely purine-free diet of low sodium content on purine intermediates and end-product.
Yamamoto T; Yokoyama H; Moriwaki Y; Takahashi S; Suda M; Hada T; Higashino K
Eur J Clin Nutr; 1990 Sep; 44(9):659-64. PubMed ID: 2261897
[TBL] [Abstract][Full Text] [Related]
38. Xylitol-induced increase in purine degradation: a role of erythrocytes.
Yamamoto T; Moriwaki Y; Suda M; Agbedana EO; Takahashi S; Nasako Y; Higashino K; Nakamo T; Hiroishi K
Int J Clin Pharmacol Ther Toxicol; 1993 Jan; 31(1):35-9. PubMed ID: 8444515
[TBL] [Abstract][Full Text] [Related]
39. Quercetin is bioavailable from a single ingestion of grape juice.
Dávalos A; Castilla P; Gómez-Cordovés C; Bartolomé B
Int J Food Sci Nutr; 2006; 57(5-6):391-8. PubMed ID: 17135030
[TBL] [Abstract][Full Text] [Related]
40. Effect of inosine on the plasma concentration of uridine and purine bases.
Yamamoto T; Moriwaki Y; Cheng J; Takahashi S; Tsutsumi Z; Ka T; Hada T
Metabolism; 2002 Apr; 51(4):438-42. PubMed ID: 11912550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
